Osteosarcoma classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Osteosarcoma]] (OS) is a rare bone cancer which affects both adolescents and young adults. Osteosarcoma was classified as primary and secondary. Later the the [[World Health Organization]] sub-typed as | [[Osteosarcoma]] (OS) is a rare bone cancer which affects both adolescents and young adults. Osteosarcoma was classified as primary and secondary. Later the the [[World Health Organization]] sub-typed as intramedullary/central and surface osteosarcoma with a number of sub-types under each group<ref name="pmid24002129">{{cite journal |vauthors=Duong LM, Richardson LC |title=Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008 |journal=J Registry Manag |volume=40 |issue=2 |pages=59–64 |date=2013 |pmid=24002129 |pmc=4476493 |doi= |url=}}</ref>. | ||
==Classification <ref name="pmid27990273">{{cite journal |vauthors=Bielack SS, Hecker-Nolting S, Blattmann C, Kager L |title=Advances in the management of osteosarcoma |journal=F1000Res |volume=5 |issue= |pages=2767 |date=2016 |pmid=27990273 |pmc=5130082 |doi=10.12688/f1000research.9465.1 |url=}}</ref><ref name="pmid24932027">{{cite journal |vauthors=Kundu ZS |title=Classification, imaging, biopsy and staging of osteosarcoma |journal=Indian J Orthop |volume=48 |issue=3 |pages=238–46 |date=May 2014 |pmid=24932027 |pmc=4052020 |doi=10.4103/0019-5413.132491 |url=}}</ref><ref name="pmid29629690">{{cite journal |vauthors=Misaghi A, Goldin A, Awad M, Kulidjian AA |title=Osteosarcoma: a comprehensive review |journal=SICOT J |volume=4 |issue= |pages=12 |date=2018 |pmid=29629690 |pmc=5890448 |doi=10.1051/sicotj/2017028 |url=}}</ref><ref name="pmid29629690">{{cite journal |vauthors=Misaghi A, Goldin A, Awad M, Kulidjian AA |title=Osteosarcoma: a comprehensive review |journal=SICOT J |volume=4 |issue= |pages=12 |date=2018 |pmid=29629690 |pmc=5890448 |doi=10.1051/sicotj/2017028 |url=}}</ref><ref name="pmid11920477">{{cite journal |vauthors=Ozaki T, Flege S, Liljenqvist U, Hillmann A, Delling G, Salzer-Kuntschik M, Jürgens H, Kotz R, Winkelmann W, Bielack SS |title=Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group |journal=Cancer |volume=94 |issue=4 |pages=1069–77 |date=February 2002 |pmid=11920477 |doi= |url=}}</ref><ref name="pmid24002129">{{cite journal |vauthors=Duong LM, Richardson LC |title=Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008 |journal=J Registry Manag |volume=40 |issue=2 |pages=59–64 |date=2013 |pmid=24002129 |pmc=4476493 |doi= |url=}}</ref><ref name="pmid12464443">{{cite journal |vauthors=Hamre MR, Severson RK, Chuba P, Lucas DR, Thomas RL, Mott MP |title=Osteosarcoma as a second malignant neoplasm |journal=Radiother Oncol |volume=65 |issue=3 |pages=153–7 |date=December 2002 |pmid=12464443 |doi= |url=}}</ref><ref name="pmid25970361">{{cite journal |vauthors=Barker JP, Monument MJ, Jones KB, Putnam AR, Randall RL |title=Secondary osteosarcoma: is there a predilection for the chondroblastic subtype? |journal=Orthopedics |volume=38 |issue=5 |pages=e359–66 |date=May 2015 |pmid=25970361 |doi=10.3928/01477447-20150504-51 |url=}}</ref>== | ==Classification <ref name="pmid27990273">{{cite journal |vauthors=Bielack SS, Hecker-Nolting S, Blattmann C, Kager L |title=Advances in the management of osteosarcoma |journal=F1000Res |volume=5 |issue= |pages=2767 |date=2016 |pmid=27990273 |pmc=5130082 |doi=10.12688/f1000research.9465.1 |url=}}</ref><ref name="pmid24932027">{{cite journal |vauthors=Kundu ZS |title=Classification, imaging, biopsy and staging of osteosarcoma |journal=Indian J Orthop |volume=48 |issue=3 |pages=238–46 |date=May 2014 |pmid=24932027 |pmc=4052020 |doi=10.4103/0019-5413.132491 |url=}}</ref><ref name="pmid29629690">{{cite journal |vauthors=Misaghi A, Goldin A, Awad M, Kulidjian AA |title=Osteosarcoma: a comprehensive review |journal=SICOT J |volume=4 |issue= |pages=12 |date=2018 |pmid=29629690 |pmc=5890448 |doi=10.1051/sicotj/2017028 |url=}}</ref><ref name="pmid29629690">{{cite journal |vauthors=Misaghi A, Goldin A, Awad M, Kulidjian AA |title=Osteosarcoma: a comprehensive review |journal=SICOT J |volume=4 |issue= |pages=12 |date=2018 |pmid=29629690 |pmc=5890448 |doi=10.1051/sicotj/2017028 |url=}}</ref><ref name="pmid11920477">{{cite journal |vauthors=Ozaki T, Flege S, Liljenqvist U, Hillmann A, Delling G, Salzer-Kuntschik M, Jürgens H, Kotz R, Winkelmann W, Bielack SS |title=Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group |journal=Cancer |volume=94 |issue=4 |pages=1069–77 |date=February 2002 |pmid=11920477 |doi= |url=}}</ref><ref name="pmid24002129">{{cite journal |vauthors=Duong LM, Richardson LC |title=Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008 |journal=J Registry Manag |volume=40 |issue=2 |pages=59–64 |date=2013 |pmid=24002129 |pmc=4476493 |doi= |url=}}</ref><ref name="pmid12464443">{{cite journal |vauthors=Hamre MR, Severson RK, Chuba P, Lucas DR, Thomas RL, Mott MP |title=Osteosarcoma as a second malignant neoplasm |journal=Radiother Oncol |volume=65 |issue=3 |pages=153–7 |date=December 2002 |pmid=12464443 |doi= |url=}}</ref><ref name="pmid25970361">{{cite journal |vauthors=Barker JP, Monument MJ, Jones KB, Putnam AR, Randall RL |title=Secondary osteosarcoma: is there a predilection for the chondroblastic subtype? |journal=Orthopedics |volume=38 |issue=5 |pages=e359–66 |date=May 2015 |pmid=25970361 |doi=10.3928/01477447-20150504-51 |url=}}</ref>== | ||
* [[Osteosarcoma]] (OS) may be classified into several subtypes based on [[World Health Organization]] and are as follows: | |||
{| class="wikitable" | {| class="wikitable" | ||
|+Classification of osteosarcoma | |+Classification of osteosarcoma | ||
Revision as of 22:22, 9 October 2019
|
Osteosarcoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Osteosarcoma classification On the Web |
|
American Roentgen Ray Society Images of Osteosarcoma classification |
|
Risk calculators and risk factors for Osteosarcoma classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammadmain Rezazadehsaatlou[2].
Overview
Osteosarcoma (OS) is a rare bone cancer which affects both adolescents and young adults. Osteosarcoma was classified as primary and secondary. Later the the World Health Organization sub-typed as intramedullary/central and surface osteosarcoma with a number of sub-types under each group[1].
Classification [2][3][4][4][5][1][6][7]
- Osteosarcoma (OS) may be classified into several subtypes based on World Health Organization and are as follows:
| Primary osteosarcoma | Conventional-intramedullary/central high grade (most common) further sub-typed as: | Osteoblastic (50%)
Chondroblastic (25%) Fibroblastic (25%) |
| Secondary osteosracomas | Unusual forms of osteosarcoma given below are viewed as subtypes of conventional osteosarcoma because their biological behavior is similar. | Osteoblastic osteosarcoma-sclerosing type
Osteosarcoma resembling osteoblastoma Chondromyxoid fibroma‑like osteosarcoma Chondroblastoma-like osteosarcoma Clear-cell osteosarcoma Malignant fibrous histiocytoma‑like osteosarcoma Giant cell rich osteosarcoma Epithelioid osteosarcoma |
| subtypes | Osteosarcoma |
|---|---|
| CENTRAL (MEDULLARY) | a. Conventional high-grade central osteosarcoma (80%)
b. Telangiectatic osteosarcoma (4%) c. Intraosseous well-differentiated (low-grade) osteosarcoma (1-2%) d. Small cell osteosarcoma (1-2%) |
| SURFACE (PERIPHERAL) | a. Parosteal (juxtacortical) well-differentiated (low-grade) osteosarcoma (4-6%)
b. Periosteal osteosarcoma - low- to intermediate-grade osteosarcoma (<4%) c. High-grade surface osteosarcoma (1%) |
References
- ↑ 1.0 1.1 Duong LM, Richardson LC (2013). "Descriptive epidemiology of malignant primary osteosarcoma using population-based registries, United States, 1999-2008". J Registry Manag. 40 (2): 59–64. PMC 4476493. PMID 24002129.
- ↑ Bielack SS, Hecker-Nolting S, Blattmann C, Kager L (2016). "Advances in the management of osteosarcoma". F1000Res. 5: 2767. doi:10.12688/f1000research.9465.1. PMC 5130082. PMID 27990273.
- ↑ Kundu ZS (May 2014). "Classification, imaging, biopsy and staging of osteosarcoma". Indian J Orthop. 48 (3): 238–46. doi:10.4103/0019-5413.132491. PMC 4052020. PMID 24932027.
- ↑ 4.0 4.1 Misaghi A, Goldin A, Awad M, Kulidjian AA (2018). "Osteosarcoma: a comprehensive review". SICOT J. 4: 12. doi:10.1051/sicotj/2017028. PMC 5890448. PMID 29629690.
- ↑ Ozaki T, Flege S, Liljenqvist U, Hillmann A, Delling G, Salzer-Kuntschik M, Jürgens H, Kotz R, Winkelmann W, Bielack SS (February 2002). "Osteosarcoma of the spine: experience of the Cooperative Osteosarcoma Study Group". Cancer. 94 (4): 1069–77. PMID 11920477.
- ↑ Hamre MR, Severson RK, Chuba P, Lucas DR, Thomas RL, Mott MP (December 2002). "Osteosarcoma as a second malignant neoplasm". Radiother Oncol. 65 (3): 153–7. PMID 12464443.
- ↑ Barker JP, Monument MJ, Jones KB, Putnam AR, Randall RL (May 2015). "Secondary osteosarcoma: is there a predilection for the chondroblastic subtype?". Orthopedics. 38 (5): e359–66. doi:10.3928/01477447-20150504-51. PMID 25970361.